22157.jpg
United States Diabetic Nephropathy Market Insights, 2016-2025 - Market Valuations, Epidemiology, Drug Sales & Shares, Competitive Landscape
June 22, 2020 07:04 ET | Research and Markets
Dublin, June 22, 2020 (GLOBE NEWSWIRE) -- The "US Diabetic Nephropathy Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering. This...
ReportLinker logo.jpg
The Asia Pacific bioreactors market is expected to reach US$ 994.52 Mn by 2027 from US$ 544.51 Mn in 2019
June 22, 2020 07:02 ET | ReportLinker
New York, June 22, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia Pacific Bioreactors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Cell ;...
Indkaldelse til ekstraordinær generalforsamling
June 22, 2020 07:01 ET | Investeringsforeningen IR Invest
Investeringsforeningen IR Invest indkalder til ekstraordinær generalforsamling, der afholdes tirsdag den 30. juni 2020, kl. 9.00. Indkaldelsen med sted, dagsorden samt fuldstændige forslag er...
Asset 1@2x-100.jpg
Caldas Gold Announces US$110 Million Precious Metals Stream with Wheaton Precious Metals on the Marmato Project; Launching Proposed Issuance of Up To US$150 Million of Units to Fund the Marmato Project Expansion
June 22, 2020 07:00 ET | Caldas Gold Corporation
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, June 22, 2020 (GLOBE NEWSWIRE) -- Caldas Gold Corp. (TSX-V: CGC) announced today that it...
LOGO.png
Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting
June 22, 2020 07:00 ET | Autolus Therapeutics plc
- AUTO5 in T cell lymphoma – new in vitro and in vivo data presented demonstrating highly selective targeting of TRBC2 by a novel CAR T candidate - AUTO6NG in small cell lung cancer – in vitro and in...
Altimmune Logo.png
Altimmune Announces IND Clearance for a Phase 2 Trial of HepTcell™ Immunotherapeutic for the Treatment of Chronic Hepatitis B
June 22, 2020 07:00 ET | Altimmune, Inc.
GAITHERSBURG, Md., June 22, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
Chimerix logo
Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer
June 22, 2020 07:00 ET | Chimerix, Inc.
DURHAM, N.C., June 22, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
p5c92dd987fc0c40004d9806b_1.png
Progressive Care Changes Independent Public Accounting Firm to Daszkal Bolton LLP
June 22, 2020 07:00 ET | Progressive Care, Inc.
MIAMI, FL, June 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company,...
RVX_logo_RGB.jpg
Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
June 22, 2020 07:00 ET | Resverlogix Corp
CALGARY, Alberta, June 22, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce that the U.S. Food & Drug Administration (FDA) has accepted its BETonMACE2...
TELABio_Logo.png
TELA Bio, Inc. to Join the Russell 2000® Index
June 22, 2020 07:00 ET | TELA Bio, Inc.
MALVERN, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of...